$129.98
BPC-157 (10mg) + TB-500 (10mg) is a dual-peptide research blend widely studied in laboratory models for its complementary roles in peptide-mediated signaling, cellular communication, and tissue-related biological pathways.
Download Wolverine (BPC-157 10mg, TB-500 10mg) CoA Here
-
Wolverine Stack (BPC-157 10mg + TB-500 10mg Blend) quantity
+
Description Additional information
BPC-157 + TB-500 Blend – Dual Peptide Research Compound
Compound Name: BPC-157 + TB-500 Blend Classification: Research Peptides – Pentadecapeptide + Thymosin Beta-4 Fragment
Description:
The BPC-157 + TB-500 blend combines two synthetic research peptides that are frequently examined together in controlled laboratory environments due to their complementary roles in peptide-mediated signaling and cellular pathway modeling.
BPC-157 is a synthetic pentadecapeptide derived from a naturally occurring gastric peptide sequence. In laboratory research, it is widely studied for its involvement in peptide-regulated signaling, cytoprotective mechanisms, and cellular communication pathways associated with tissue modeling and biological adaptation.
TB-500 is a synthetic active fragment of thymosin beta-4, a naturally occurring intracellular protein. TB-500 is commonly studied in research settings for its role in actin-related cellular processes, peptide-mediated signaling, and molecular pathways involved in cell migration and structural regulation.
When examined together, this dual-peptide combination is frequently utilized in in-vitro and biochemical research models to explore coordinated peptide signaling, receptor-mediated pathway interactions, and complex cellular response mechanisms.
Scientific References:
Gwyer D, Wragg NM, Wilson SL., Cell and Tissue Research, 2019; 377(2):153–159 – Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing Józwiak M, Bauer M, Kamysz W, Kleczkowska P., Pharmaceuticals (Basel), 2025; 18(2):185 – Multifunctionality and possible medical application of the BPC 157 peptide: literature and patent review Bock-Marquette I, Maar K, Maar S, Lippai B, Faskerti G, Gallyas F Jr, Olson EN, Srivastava D., International Immunopharmacology, 2023; 116:109741 – Thymosin beta-4 denotes new directions towards developing regenerative biological models
Disclaimer:
This product is intended for laboratory research use only (RUO). Not for human consumption. Not for therapeutic, diagnostic, agricultural, or veterinary use.
Additional information
Size
20 mg